Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva Considers 10,000 Job Cuts - Bloomberg
Teva flags supply constraints to ADHD drug Adderall as demand rises (NYSE: TEVA) | Seeking Alpha
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Drugmaker Teva Misled Court to Dodge Opioid Trial, New York State Claims - Bloomberg
Teva considering cutting up to 10,000 jobs: Bloomberg
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva's Working With Evercore to Review Debt Options - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Kare Schultz, president and chief executive officer of Teva... Fotografía de noticias - Getty Images
Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts - Bloomberg
Buffett's Berkshire Takes Activision Blizzard Stake, Exits Teva - BNN Bloomberg
Teva, Allergan ready to pay $5B to settle thousands of opioid lawsuits (TEVA) | Seeking Alpha
America's Most Beloved Pharmaceutical Stock Is Israel's Teva - Bloomberg
Zantac Cancer Case in US Settles for $500,000 (PRGO, TEVA) - Bloomberg
Teva, AbbVie may pay billions to settle opioid lawsuits
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - BNN Bloomberg
Soriot not moving to Teva - Bloomberg - Globes
Glaxo's Win in Case Against Teva Lifts Other Drugmakers - Bloomberg
Análisis: Teva cae cerca de un 0,20% en el premarket | IG España
